Latest Trials
| EudraCT Number: 2004-001491-39 | Sponsor Protocol Number: 03-0-192 | Start Date: 2005-02-16 | |||||||||||
| Sponsor Name: Astellas Pharma US, Inc. | |||||||||||||
| Full Title: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, COMPARATIVE STUDY OF MICAFUNGIN (FK463) VERSUS CASPOFUNGIN AS ANTIFUNGAL TREATMENT IN PATIENTS WITH INVASIVE CANDIDIASIS OR CANDIDEMIA | |||||||||||||
| Medical condition: Invasive candidiasis or candidemia | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: CZ (Completed) GB (Completed) BE (Completed) AT (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||